Published in Bioinformatics on April 12, 2005
The importance of discerning shape in molecular pharmacology. Trends Pharmacol Sci (2009) 1.17
Sequence based residue depth prediction using evolutionary information and predicted secondary structure. BMC Bioinformatics (2008) 0.97
Guanidinoneomycin B recognition of an HIV-1 RNA helix. Chembiochem (2008) 0.96
Enzymatic excision of uracil residues in nucleosomes depends on the local DNA structure and dynamics. Biochemistry (2012) 0.93
Prodepth: predict residue depth by support vector regression approach from protein sequences only. PLoS One (2009) 0.87
Studying the structure and dynamics of biomolecules by using soluble paramagnetic probes. Chemphyschem (2013) 0.87
Measuring the dynamic surface accessibility of RNA with the small paramagnetic molecule TEMPOL. Nucleic Acids Res (2007) 0.84
Cosolute paramagnetic relaxation enhancements detect transient conformations of human uracil DNA glycosylase (hUNG). Biochemistry (2011) 0.82
Adepth: New Representation and its implications for atomic depths of macromolecules. Nucleic Acids Res (2013) 0.78
On Nature's Strategy for Assigning Genetic Code Multiplicity. PLoS One (2016) 0.77
Shape and evolution of thermostable protein structure. Proteins (2010) 0.76
NMR studies on structure and dynamics of the monomeric derivative of BS-RNase: new insights for 3D domain swapping. PLoS One (2012) 0.75
Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci U S A (2005) 3.37
FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet (2008) 2.65
Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein. Biochem Biophys Res Commun (2003) 1.16
Interdomain tilt angle determines integrin-dependent function of the ninth and tenth FIII domains of human fibronectin. J Biol Chem (2004) 1.10
Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3. J Biol Chem (2006) 1.10
Structure and thermodynamics of a conserved U2 snRNA domain from yeast and human. RNA (2007) 1.08
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. Antimicrob Agents Chemother (2005) 1.06
Molecular basis of branched peptides resistance to enzyme proteolysis. Chem Biol Drug Des (2007) 1.03
Revealing the complexity of a monogenic disease: rett syndrome exome sequencing. PLoS One (2013) 1.02
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. FASEB J (2009) 1.00
Prediction of quaternary assembly of SARS coronavirus peplomer. Biochem Biophys Res Commun (2004) 1.00
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis. Infect Immun (2003) 0.98
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting. Mol Cancer Ther (2007) 0.98
Guanidinoneomycin B recognition of an HIV-1 RNA helix. Chembiochem (2008) 0.96
Bioactive peptides from libraries. Chem Biol (2005) 0.96
Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus. Antivir Ther (2005) 0.95
Structure, dynamics and biophysics of the cytoplasmic protein-protein complexes of the bacterial phosphoenolpyruvate: sugar phosphotransferase system. Trends Biochem Sci (2013) 0.95
Branched peptides as therapeutics. Curr Protein Pept Sci (2008) 0.94
Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution. Int Immunol (2004) 0.92
Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agents. ChemMedChem (2010) 0.92
Target-selective drug delivery through liposomes labeled with oligobranched neurotensin peptides. ChemMedChem (2011) 0.91
Minimum-energy path for a u6 RNA conformational change involving protonation, base-pair rearrangement and base flipping. J Mol Biol (2009) 0.90
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency. Chem Biol (2003) 0.90
NMR studies of protein hydration and TEMPOL accessibility. J Mol Biol (2003) 0.89
NMR studies of the inclusion complex between beta-cyclodextrin and paroxetine. Eur J Pharm Sci (2004) 0.88
Hereditary neuronal intranuclear inclusion disease with autonomic failure and cerebellar degeneration. Arch Neurol (2002) 0.87
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. J Med Chem (2013) 0.87
Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate. Int J Cancer (2006) 0.87
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. J Pept Sci (2007) 0.87
A NMR experiment for simultaneous correlations of valine and leucine/isoleucine methyls with carbonyl chemical shifts in proteins. J Biomol NMR (2013) 0.86
Structure-activity relationships and mechanism of action of Eph-ephrin antagonists: interaction of cholanic acid with the EphA2 receptor. ChemMedChem (2012) 0.86
Mycobacterium tuberculosis chaperonin 10 is secreted in the macrophage phagosome: is secretion due to dissociation and adoption of a partially helical structure at the membrane? J Bacteriol (2003) 0.86
The development of antimicrobial peptides as new antibacterial drugs. Curr Protein Pept Sci (2013) 0.86
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo. Biochem J (2006) 0.85
Nanoparticles exposing neurotensin tumor-specific drivers. J Pept Sci (2013) 0.85
Protein-thiol substitution or protein dethiolation by thiol/disulfide exchange reactions: the albumin model. Proteins (2007) 0.84
Strategies for the construction and use of peptide and antibody libraries displayed on phages. Curr Protein Pept Sci (2004) 0.84
cDNA cloning and expression of the phytoene synthase gene in sunflower. J Plant Physiol (2005) 0.84
Measuring the dynamic surface accessibility of RNA with the small paramagnetic molecule TEMPOL. Nucleic Acids Res (2007) 0.84
A structurally driven analysis of thiol reactivity in mammalian albumins. Biopolymers (2010) 0.83
NMR studies on the surface accessibility of the archaeal protein Sso7d by using TEMPOL and Gd(III)(DTPA-BMA) as paramagnetic probes. Biophys Chem (2008) 0.83
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin. Biochemistry (2002) 0.82
Models of In-Vivo Bacterial Infections for the Development of Antimicrobial Peptide-based Drugs. Curr Top Med Chem (2017) 0.81
MD and NMR studies of alpha-bungarotoxin surface accessibility. Biochem Biophys Res Commun (2007) 0.81
Peptide-protein interactions studied by surface plasmon and nuclear magnetic resonances. FEBS Lett (2002) 0.81
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions. Amino Acids (2011) 0.81
Hydration studies on the archaeal protein Sso7d using NMR measurements and MD simulations. BMC Struct Biol (2011) 0.80
Isomerization of an antimicrobial peptide broadens antimicrobial spectrum to gram-positive bacterial pathogens. PLoS One (2012) 0.80
Oligo-branched peptides for tumor targeting: from magic bullets to magic forks. Expert Opin Biol Ther (2009) 0.80
NMR studies of BPTI aggregation by using paramagnetic relaxation reagents. Biochim Biophys Acta (2006) 0.80
NMR studies of lysozyme surface accessibility by using different paramagnetic relaxation probes. J Am Chem Soc (2006) 0.80
NMR structure of alpha-bungarotoxin free and bound to a mimotope of the nicotinic acetylcholine receptor. Biochemistry (2002) 0.80
Branched peptides as novel tumor-targeting agents for bladder cancer. Expert Rev Anticancer Ther (2012) 0.80